Clinical outcome of colorectal cancer patients treated with human monoclonal anti‐idiotypic antibody
- 1 April 1994
- journal article
- clinical trial
- Published by Wiley in International Journal of Cancer
- Vol. 57 (1) , 10-14
- https://doi.org/10.1002/ijc.2910570103
Abstract
A human monoclonal anti‐idiotypic antibody (105AD7) has been developed which mimics a colorectal‐tumour‐associated antigen and induces cellular anti‐colorectal tumour immune responses in animals. Thirteen patients with advanced colorectal cancer were immunized with 105AD7 and their survival was compared with that of a contemporary group of unimmunized patients with similar disease status. No toxicity related to anti‐idiotype immunization was seen. Cellular responses to anti‐idiotypic immunization were indicated by lymphocyte proliferation to gp72‐positive tumour cells, and production of interleukin‐2; anti‐tumour antibodies were not detected. Median survival following diagnosis of advanced disease of immunized patients was 12 months, compared with 4 months in unimmunized patients. The improved survival of immunized patients in this study without associated toxicity suggests that 105AD7 immunization may have considerable potential for immunotherapy of colorectal cancer. © Wiley‐Liss, Inc.Keywords
This publication has 18 references indexed in Scilit:
- Murine monoclonal anti-idiotope antibody breaks unresponsiveness and induces a specific antibody response to human melanoma-associated proteoglycan antigen in cynomolgus monkeys.Proceedings of the National Academy of Sciences, 1992
- An idiotypic replica of carcinoembryonic antigen inducing cellular and humoral responses directed against human colorectal tumoursInternational Journal of Cancer, 1992
- Human high molecular weight melanoma-associated antigen (HMW-MAA) mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: induction of humoral anti-HMW-MAA immunity and prolongation of survival in patients with stage IV melanoma.Proceedings of the National Academy of Sciences, 1992
- Induction of Delayed Hypersensitivity to Human Tumor Cells With a Human Monoclonal Anti-idiotypic AntibodyJNCI Journal of the National Cancer Institute, 1991
- Patients treated with a monoclonal antibody (ab1) to the colorectal carcinoma antigen 17–1A develop a cellular response (DTH) to the “internal image of the antigen” (ab2)International Journal of Cancer, 1991
- Murine monoclonal anti-idiotype antibody as a potential network antigen for human carcinoembryonic antigen.The Journal of Immunology, 1990
- Immunoreactivity of patient with colorectal cancer metastasis after immunisation with anti-idiotypesThe Lancet, 1990
- Anti-idiotype immunization of cancer patients: modulation of the immune response.Proceedings of the National Academy of Sciences, 1987
- Natural history of patients with untreated liver metastases from colorectal cancerThe American Journal of Surgery, 1981
- Appraisal of methods for the study of chemotherapy of cancer in man: Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramideJournal of Chronic Diseases, 1960